Anti-GPNMB-VC-MMAE ADC

  • 1.00 Dollar US$
  • Published date: December 8, 2018
    • Shirley, New York, United States

This ADC product is comprised of an anti-GPNMB monoclonal antibody conjugated via a VC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-gpnmb-51.htm

Result 0 votes
Bella
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-Fyn3 (clone SC16)-D6.5 ADC

    Anti-Fyn3 (clone SC16)-D6.5 ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-Fyn3 monoclonal antibody (clone SC16) conjugated via a linker to D6.5. https://www.creative-biolabs.com/adc/target-fyn3-50.htm

  • Anti-FXYD5 (clone M53)-PEG-cardiac glycoside ADC

    Anti-FXYD5 (clone M53)-PEG-cardiac glycoside ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-FXYD5 monoclonal antibody (clone M53) conjugated via a PEG linker to cardiac glycoside. https://www.creative-biolabs.com/adc/target-fxyd5-49.htm

  • Anti-FUT3 (clone BR96)-Mc-VC-PABC-MMAF ADC

    Anti-FUT3 (clone BR96)-Mc-VC-PABC-MMAF ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone BR96) conjugated via a Mc-VC-PABC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....